Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

2.

beta-Methylamino-L-alanine (BMAA) and amyotrophic lateral sclerosis-parkinsonism dementia of the western Pacific.

Duncan MW.

Ann N Y Acad Sci. 1992 May 11;648:161-8. Review. No abstract available.

PMID:
1637043
3.

Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis.

Bradley WG.

Amyotroph Lateral Scler. 2009;10 Suppl 2:118-23. doi: 10.3109/17482960903285951. Review.

PMID:
19929743
4.

Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.

Banack SA, Metcalf JS, Bradley WG, Cox PA.

Toxicon. 2014 Nov;90:167-73. doi: 10.1016/j.toxicon.2014.07.018. Epub 2014 Aug 11.

PMID:
25123936
5.

BMAA--an unusual cyanobacterial neurotoxin.

Vyas KJ, Weiss JH.

Amyotroph Lateral Scler. 2009;10 Suppl 2:50-5. doi: 10.3109/17482960903268742.

PMID:
19929732
6.

Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.

Papapetropoulos S.

Neurochem Int. 2007 Jun;50(7-8):998-1003. Epub 2007 Jan 14. Review.

PMID:
17296249
7.

beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).

Liu X, Rush T, Zapata J, Lobner D.

Exp Neurol. 2009 Jun;217(2):429-33. doi: 10.1016/j.expneurol.2009.04.002. Epub 2009 Apr 15.

PMID:
19374900
8.

Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.

Cox PA, Banack SA, Murch SJ.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13380-3.

9.

Neurotoxic Non-proteinogenic Amino Acid β-N-Methylamino-L-alanine and Its Role in Biological Systems.

Popova AA, Koksharova OA.

Biochemistry (Mosc). 2016 Aug;81(8):794-805. doi: 10.1134/S0006297916080022. Review.

PMID:
27677549
10.

Three phases of research on beta-N-methylamino-L-alanine (BMAA)--a neurotoxic amino acid.

Nunn PB.

Amyotroph Lateral Scler. 2009;10 Suppl 2:26-33. doi: 10.3109/17482960903272975.

PMID:
19929728
11.

Morphometric and neurochemical alterations found in l-BMAA treated rats.

de Munck E, Muñoz-Sáez E, Miguel BG, Solas MT, Martínez A, Arahuetes RM.

Environ Toxicol Pharmacol. 2015 May;39(3):1232-45. doi: 10.1016/j.etap.2015.04.022. Epub 2015 May 11.

PMID:
26002186
12.

Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease?

Metcalf JS, Codd GA.

Amyotroph Lateral Scler. 2009;10 Suppl 2:74-8. doi: 10.3109/17482960903272942.

PMID:
19929737
13.

Linking β-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MD.

Field NC, Metcalf JS, Caller TA, Banack SA, Cox PA, Stommel EW.

Toxicon. 2013 Aug;70:179-83. doi: 10.1016/j.toxicon.2013.04.010. Epub 2013 May 6.

PMID:
23660330
14.

Human exposure to cyanobacteria and BMAA.

Brand LE.

Amyotroph Lateral Scler. 2009;10 Suppl 2:85-95. doi: 10.3109/17482960903273585.

PMID:
19929739
15.

Distinguishing the cyanobacterial neurotoxin beta-N-methylamino-L-alanine (BMAA) from its structural isomer 2,4-diaminobutyric acid (2,4-DAB).

Banack SA, Downing TG, Spácil Z, Purdie EL, Metcalf JS, Downing S, Esterhuizen M, Codd GA, Cox PA.

Toxicon. 2010 Nov;56(6):868-79. doi: 10.1016/j.toxicon.2010.06.006. Epub 2010 Jun 16.

PMID:
20561540
16.

A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.

Murch SJ, Cox PA, Banack SA.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12228-31. Epub 2004 Aug 4.

17.

A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms.

Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, Ball A, Harris BT, Stommel EW.

Amyotroph Lateral Scler. 2009;10 Suppl 2:101-8. doi: 10.3109/17482960903278485.

PMID:
19929741
18.

Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination.

Porojan C, Mitrovic SM, Yeo DC, Furey A.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016 Oct;33(10):1570-1586. Epub 2016 Sep 22. Review.

PMID:
27652898
19.

Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.

Stommel EW, Field NC, Caller TA.

Med Hypotheses. 2013 Feb;80(2):142-5. doi: 10.1016/j.mehy.2012.11.012. Epub 2012 Dec 14.

PMID:
23246360
20.

Toxicity of the cyanobacterial neurotoxin beta-N-methylamino-L-alanine to three aquatic animal species.

Purdie EL, Metcalf JS, Kashmiri S, Codd GA.

Amyotroph Lateral Scler. 2009;10 Suppl 2:67-70. doi: 10.3109/17482960903273551.

PMID:
19929735

Supplemental Content

Support Center